Introduction
The term catastrophic antiphospholipid syndrome (CAPS) was first coined in 1992. It was found to be a rare thrombotic condition in a little more than 1% of all cases of antiphospholipid syndrome (APS) [1, 2] . CAPS is diagnosed if there is acute multiorgan failure due to the presence of thrombosis of three or more organs simultaneously or within 1 week with the findings of antiphospholipid antibodies and small-vessel thrombosis on histology [3] . It can arise as the first clinical presentation with no prior history of APS; it may also be triggered after anticoagulation withdrawal, infections, surgery, trauma in patients previously diagnosed with APS. Anticoagulation, high-dose steroids, intravenous (i.v.) immune globulin and/or plasma exchange are given when CAPS is clinically suspected. Even with treatment, the mortality rate can be as high as 50%. CAPS can cause thrombosis in any vessel or organ, similar to HIT. Because thrombocytopenia is one of the possible clinical features of CAPS and found in more than 60% of cases of CAPS [3] , it can be difficult for clinicians to distinguish it from HIT in the midst of an acute thrombotic state.
HIT is a thrombotic disorder with the clinical presentation of thrombocytopenia that typically develops within 5-10 days after being treated with heparin due to development of antibodies to heparin and platelet factor 4 [4] . HIT is an immune-mediated thrombotic disorder with significant thrombocytopenia (50% or more drop from the baseline) [5, 6] . The incidence of HIT in patients started on low molecular weight heparin (LMWH) or unfractionated heparin is 0.2-5% depending on the study [5, [7] [8] [9] [10] [11] [12] . Although thrombocytopenia is usually found 5-10 days after heparin has been started, there have been reports in which it can manifest more than 100 days after being exposed to heparin [13] . Both CAPS and HIT can cause life or limb-threatening widespread thrombosis if not recognized early and treated. Deep venous thrombosis and pulmonary embolism are the most common thrombotic disorders in both conditions [14] [15] [16] [17] [18] . It therefore can be hypothesized that CAPS and HIT may be interrelated diseases due to sharing similar clinical presentations produced by autoimmune-mediated antibodies [19] .
Case presentation
Case 1 A 37-year-old white man presented with chronic nonhealing ulcers for one and a half months, complicated by the recent development of cellulitis of both lower extremities. Previous investigations had revealed only bilateral nonocclusive deep vein thromboses of lower extremities and a skin biopsy done was unrevealing for vasculitis. While in the hospital, he developed severe acute hypoxia along with tachycardia, hypotension and acute renal failure. An urgent ventilation perfusion study showed high probability scan with multiple perfusion defects in both lungs ( Fig. 1) . A trans-thoracic echocardiogram showed evidence of severe right ventricular strain with shift of the inter-ventricular septum. The estimated pulmonary systolic pressure was 61 mmHg. The patient was emergently intubated and mechanically ventilated. He was systemically thrombolysed with alteplase 100 mg i.v. over 2 h. He was also started on anticoagulation with unfractionated heparin with 80 units/kg i.v. bolus and then maintenance infusion at 18 units/kg per h with target activated partial thromboplastin time (APTT) 1.5-2 times of control. APTT was 40 s and international normalized ratio (INR) was 1.1 before starting heparin. Systemic coagulation markers were measured. However, heparin had already been started. Low protein C activity with 16% (normal 70-180%) and low protein S activity with 44% (normal 70-150%), low antithrombin activity with 65% (normal 83-122%) and high factor VIII level 224% (normal 59-159%) were found. Low fibrinogen level of 110 mg/dl (normal 193-411 mg/dl) was noted. Further workup showed positive anticardiolipin IgG at 50 IgG phospholipid units (GPL)/ml (normal: less than 10 GPL/ml) and anticardiolipin IgM at 28 IgM phospholipid units (MPL)/ml (normal: less than 10 MPL/ml). He also developed acute hepatic injury with aspartate aminotransferase (AST) maximum more than 12 000 U/l and alanine aminotransferase (ALT) maximum more than 4000 U/l. His multiorgan failure was felt to be secondary to thrombotic angiopathy from CAPS. Low level of fibrinogen in this case was felt to be due to underlying abnormal liver function. Treatment with i.v. immunoglobulin therapy and systemic corticosteroids did not improve his multiorgan failure and was subsequently CAPS and HIT Tun et al. 215 treated with three cycles of plasmapheresis. Five days after starting heparin therapy, he developed profound thrombocytopenia (20Â10 9 /l). Heparin-associated platelet factor 4 antibodies done by ELISA were negative. However, due to strong possibility of heparin-induced thrombocytopenia, heparin was stopped and the patient was started on argatroban. His platelet count improved to baseline in 10 days after substituting argatroban for heparin. He also received continuous renal replacement therapy with continuous veno-venous hemodiafiltration.
His stay was further complicated by multiple pulmonary infarcts and super-infection with Candida. Despite his long and complex hospitalization, he recovered completely and was discharged home on anticoagulation with warfarin due to the presence of high Factor VIII level and one episode of CAPS.
Case 2
A 42-year-old white woman with a history of resection of fibroid tumours on oestrogen replacement presented with dyspnoea for 2 weeks that did not improve with oral antibiotics prescribed for treating left lower lobe community acquired pneumonia. Physical examination showed bilateral vesicular breath sounds with no crackles. CT angiogram of the abdomen showed mesenteric ischemia with a thrombus in the mid superior mesenteric artery (Fig. 2) . Multiple areas of infarct in liver, right kidney and spleen were also seen. An exploratory laparotomy with small bowel resection with ileocolic anastomosis was urgently performed. CT scan of the brain showed tiny haemorrhages in the right frontal and parietal lobes. Echocardiogram showed normal ejection fraction (60-65%) with no thrombus and no patent foramen ovale. Due to the presence of multiorgan infarcts, there was a high clinical suspicion for CAPS. Anticardiolipin and anti-b2 glycoprotein I antibodies were negative, whereas the lupus anticoagulant was positive. ANA titres were 1 : 160, in a speckled pattern. Double-stranded DNA antibodies were normal. The patient was treated with plasmapheresis. His platelet count dropped from 307 Â 10 9 /l to 115 Â 10 9 /l over 7 days while on heparin drip. Heparin was stopped and fondaparinux was started with the subsequent resolution of his thrombocytopenia. The patient symptomatically improved, the patient's acute encephalopathy resolved and she was discharged home in a stable condition. Computed tomography of abdomen and pelvis with contrast shows thrombus in mid superior mesenteric artery with filling defect (middle arrow), infarcts in right kidney (black arrow) and large infarct in liver (white arrow).
criteria for the diagnosis TTP. The patient was transferred to University of Pennsylvania for plasmapheresis.
Seven years later in September 2013, the same patient presented with multiple episodes of hematochezia after eating breakfast. Before admission, the patient had been on 0.5 mg of warfarin on 3 days in a week. He was given fresh frozen plasma for an INR of 3.5 on admission. A colonoscopy showed internal haemorrhoids. He experienced dizziness and episodes of left-sided facial numbness lasting a few minutes while in the hospital. CT scan of brain did not reveal any acute intracranial disease. Transient ischemic attacks due to underlying APS were suspected. MRI of brain was not pursued as patient had a defibrillator. He also had acute kidney failure with change of creatinine from 1. 24 (Fig. 3) . CAPS was suspected. Further workup showed positive anticardiolipin IgG at more than 150 GPL/ml (normal: less than 14 GPL/ml) and anticardiolipin IgM at more than 150 MPL/ml (normal: less than 12 MPL/ml). He was treated with steroids and i.v. immunoglobulin with six cycles of plasmapheresis. Fibrinogen levels were followed closely following plasmapheresis and the patient received cryoprecipitate replacement when the fibrinogen level became less than 100 mg/dl during therapy with plasmapheresis. He improved clinically and facial flushing and dizziness resolved. His creatinine improved to 1.9 mg/dl while on plasmapheresis. He was discharged home on fondaparinux for bridging and warfarin.
Discussion
Both CAPS and HIT are acquired autoimmune diseases caused by different autoantibodies. Although both of these diseases are possibly fatal, patients can be carriers of these antibodies without demonstrating any symptoms. CAPS and HIT are usually triggered by the production of excessive specific antibodies following a precipitating event such as infection, trauma, surgery or subtherapeutic anticoagulation. Recurrent foetal loss and neurological manifestations such as seizures are specific to APS; these two clinical features are not found in HIT [19] . Thrombosis of any organ can be found in both CAPS and HIT.
In CAPS, thrombocytopenia can be found in two-thirds of patients, while haemolytic anaemia is noted in one-third of the cases. The finding of schistocytes is rare but not uncommon in CAPS [20, 21] . Therefore, CAPS has to be distinguished from TTP, HIT and disseminated intravascular coagulation (DIC) [22] . DIC can be a rare but possible complication of CAPS and found in 20-28% of cases [20, 21] . Therefore, in patients with unclear cause of DIC, the antiphospholipid antibodies should be checked [23] . Treatment with heparin could be considered in two conditions of DIC: acute DIC in which excess fibrin deposition with intravascular thrombosis (e.g. purpura fulminans, digital ischemia) with no major bleeding in other parts of the body and chronic DIC [24] [25] [26] [27] . Enoxaparin (LMWH) is preferred over unfractionated heparin due to less haemorrhage complications [28] . Treatment with antithrombin concentrate could improve DIC symptoms in some studies including sepsis [28, 29] .
In CAPS, a severe thrombotic state with excess thrombin generation occurs due to decreased activity of activated protein C [30] . Antiphospholipid antibodies can inhibit the activation of protein C by inhibiting thrombinthrombomodulin complex formation and binding to its cofactor protein S. These antibodies can also inhibit protein C action by preventing factor Va and VIIIa to be proteolysed [31, 32] . Antiphospholipid antibodies can cause a hypercoagulant state by disrupting the anthithrombin binding area to heparan sulfate, heparin and other glycosaminoglycans (GAGs) on the endothelial cells, causing malfunction of anthithrombin [33] . Antithrombin is one of the strong inhibitors of coagulation cascade and its activity is increased after being bound by heparin [32] . arterial or venous thrombosis [14] [15] [16] [17] 19, 34, 35] . In APS, antibodies against proteins that interact with phospholipids such as antib2 glycoprotein I are also found [36] . Antiphospholipid antibodies were found to be able to bind to heparin [37] and could possibly produce heparin autoantibodies. Activation of platelets with increased production of platelet factor 4, which in turn attaches to heparan sulfate on the endothelial cells, can result in formation of further antiheparin antibodies [19] .
HIT is a type 2 immune-mediated hypercoagulable disorder. In HIT, antibodies against heparin-platelet factor 4 complex usually with Ig G variant [38] result in destruction of platelets with thrombocytopenia. HIT antibodies that bind to the platelets via FcURIIa receptors cause further activation of platelets and formation of platelet-rich thrombi [39] [40] [41] . Vascular endothelium rich in GAG with heparan sulfate is also attached by platelet factor 4. This results in damage to the vascular endothelium, as HIT antibodies follow heparin-platelet factor 4 complexes. It is hypothesized that exposure of phospholipids with destruction of endothelial surface in HIT can cause antiphospholipid antibodies [19] .
In case 1 and case 2, our patients developed HIT soon after heparin had been started for the treatment of CAPS. In case 1, CAPS was likely triggered by cellulitis of bilateral lower extremities. In case 2, CAPS was possibly elicited by pneumonia. These two patients had a de-novo type of CAPS. In case 3, our patient with a history of APS had HIT. This patient developed CAPS years later. Although heparin antibodies can remain in the body for no more than 90 days, the emphasis of case 3 was that patients with APS who developed HIT can still present with CAPS at any time.
Conclusion
HIT and CAPS are two life-threatening and possibly closely related immune-mediated diseases with the potential ability to induce the other disease's autoantibodies separate from its specific autoantibodies. Therefore, clinicians should be aware that HIT may occur after the patient is treated with heparin for CAPS, as the treatment is completely different in CAPS compared with HIT. In CAPS, early anticoagulation with heparin and plasmapheresis are recommended. In HIT, withdrawal of heparin along with initiation of direct thrombin inhibitors are recommended.
